scFv antibodies which pass epithelial and/or endothelial layers

Details for Australian Patent Application No. 2007272224 (hide)

Owner ESBATech AG

Inventors Barberis, Alcide; Urech, David; Auf Der Maur, Adrian; Lichtlen, Peter

Agent Davies Collison Cave

Pub. Number AU-A-2007272224

PCT Pub. Number WO2008/006235

Priority 60/819,378 10.07.06 US; 60/899,907 06.02.07 US

Filing date 10 July 2007

Wipo publication date 17 January 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 27/02 (2006.01) Drugs for disorders of the senses

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

19 February 2009 PCT application entered the National Phase

  PCT publication WO2008/006235 Priority application(s): WO2008/006235

27 May 2010 Alteration of Name

  The name of the applicant has been altered to ESBATech, an Alcon Biomedical Research Unit LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007272229-Louvre assembly system

2007272187-Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof